Better home lighting may help people with glaucoma get more steps, move faster
By
Kristen Fischer
Feb 09, 2024
Adequate lighting at home can help older adults with visual impairments move more, and more quickly. But more research is needed to see if modifications can improve this population’s physical activity...
Clinical briefs for Tuesday, Aug. 22
By
Kristen Fischer
Aug 21, 2023
FDA gives OK to higher dose of eye disease drug … Shingles, pneumonia shots may lower Alzheimer’s risk … More findings on the Parkinson’s, gut link … Being bilingual may offer a memory perk...
Key study links eyesight loss with dementia
By
Kristen Fischer
Jul 14, 2023
Eyesight loss could be linked to dementia. If confirmed, it could be officially recognized as a risk factor for the disease, according to a new pivotal study.
Preventable diseases tied to common, age-related eye condition, study finds
By
Alicia Lasek
Jan 11, 2023
Age-related macular degeneration is linked to two potentially treatable diseases, suggesting new pathways for preventing progression and blindness, investigators say.
Clinical briefs for Tuesday, Feb. 1
By
Alicia Lasek
Feb 01, 2022
FDA approves eye drug Vabysmo to treat ‘wet’ macular degeneration in older adults … Diet rich in flavonoid-rich foods boosts longevity in Parkinson’s disease … Allopurinol not linked to higher...
FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
Roche’s eye implant may reduce vision loss treatment time for seniors
By
Alicia Lasek
Oct 26, 2021
The FDA has approved an ocular implant that could reduce the treatment schedule from monthly to twice yearly for older adults with “wet” macular degeneration.
FDA approves first nasal spray for chronic dry eyes
By
Alicia Lasek
Oct 19, 2021
Sprayed twice daily into each nostril, Tyrvaya reduced eye dryness within four weeks in clinical trials. The medication will be available by prescription beginning in November, the developer says.
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
Eye drop corrects late-life vision loss in trial; Allergan reports patients’ feedback
By
Alicia Lasek
May 10, 2021
Trial participants reported significant near-vision improvements under low-light conditions — without losing distance vision, reports Allergan, which is seeking FDA approval for the drug.